Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: Long-term primate study

Isao Date, Tetsuro Shingo, Hideyuki Yoshida, Kenjiro Fujiwara, Kazuki Kobayashi, Takashi Ohmoto

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The transplantation of encapsulated dopamine-secreting cells into the striatum represents one potential means of treating Parkinson's disease. The present study investigated the ability of encapsulated PC12 cells, which are derived from rat pheochromocytoma, to supply L-dopa and dopamine into the primate brain in the long term and to effect functional improvement in the animals. Following polymer encapsulation, PC12 cells were transplanted into the striatum of hemiparkinsonian monkeys. The secretion of L-dopa and dopamine from the encapsulated cells, the morphology of these cells, the histology of the host striatum surrounding the capsule, and functional changes in the host animals were examined 1, 6, and 12 months after transplantation. Analysis of retrieved capsules revealed that the PC12 cells survived and continued to release L-dopa and dopamine even 12 months after transplantation. The histological response of the host brain surrounding the capsules was minimal and there were no signs of immunological rejection or tumor formation. The physical condition of the host animals was good for 12 months, and hematologic and cerebrospinal fluid analysis revealed that no animals suffered from infection or immunological reaction. These PC12 cell-grafted monkeys showed improvements in hand movements after transplantation, effects that lasted for at least 12 months. These results further support the potential use of this approach for the treatment of Parkinson's disease.

Original languageEnglish
Pages (from-to)705-709
Number of pages5
JournalCell Transplantation
Volume9
Issue number5
Publication statusPublished - 2000

Fingerprint

PC12 Cells
Primates
Parkinson Disease
Dopamine
Animals
Levodopa
Transplantation
Capsules
Haplorhini
Brain
Cerebrospinal fluid
Histology
Pheochromocytoma
Encapsulation
Cerebrospinal Fluid
Rats
Tumors
Polymers
Hand
Infection

Keywords

  • Encapsulation
  • Neural transplantation
  • Parkinson's disease
  • PC12 cells

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation

Cite this

Date, I., Shingo, T., Yoshida, H., Fujiwara, K., Kobayashi, K., & Ohmoto, T. (2000). Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: Long-term primate study. Cell Transplantation, 9(5), 705-709.

Grafting of encapsulated dopamine-secreting cells in Parkinson's disease : Long-term primate study. / Date, Isao; Shingo, Tetsuro; Yoshida, Hideyuki; Fujiwara, Kenjiro; Kobayashi, Kazuki; Ohmoto, Takashi.

In: Cell Transplantation, Vol. 9, No. 5, 2000, p. 705-709.

Research output: Contribution to journalArticle

Date, I, Shingo, T, Yoshida, H, Fujiwara, K, Kobayashi, K & Ohmoto, T 2000, 'Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: Long-term primate study', Cell Transplantation, vol. 9, no. 5, pp. 705-709.
Date, Isao ; Shingo, Tetsuro ; Yoshida, Hideyuki ; Fujiwara, Kenjiro ; Kobayashi, Kazuki ; Ohmoto, Takashi. / Grafting of encapsulated dopamine-secreting cells in Parkinson's disease : Long-term primate study. In: Cell Transplantation. 2000 ; Vol. 9, No. 5. pp. 705-709.
@article{18f7520368c84ea79794d13d75de53c7,
title = "Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: Long-term primate study",
abstract = "The transplantation of encapsulated dopamine-secreting cells into the striatum represents one potential means of treating Parkinson's disease. The present study investigated the ability of encapsulated PC12 cells, which are derived from rat pheochromocytoma, to supply L-dopa and dopamine into the primate brain in the long term and to effect functional improvement in the animals. Following polymer encapsulation, PC12 cells were transplanted into the striatum of hemiparkinsonian monkeys. The secretion of L-dopa and dopamine from the encapsulated cells, the morphology of these cells, the histology of the host striatum surrounding the capsule, and functional changes in the host animals were examined 1, 6, and 12 months after transplantation. Analysis of retrieved capsules revealed that the PC12 cells survived and continued to release L-dopa and dopamine even 12 months after transplantation. The histological response of the host brain surrounding the capsules was minimal and there were no signs of immunological rejection or tumor formation. The physical condition of the host animals was good for 12 months, and hematologic and cerebrospinal fluid analysis revealed that no animals suffered from infection or immunological reaction. These PC12 cell-grafted monkeys showed improvements in hand movements after transplantation, effects that lasted for at least 12 months. These results further support the potential use of this approach for the treatment of Parkinson's disease.",
keywords = "Encapsulation, Neural transplantation, Parkinson's disease, PC12 cells",
author = "Isao Date and Tetsuro Shingo and Hideyuki Yoshida and Kenjiro Fujiwara and Kazuki Kobayashi and Takashi Ohmoto",
year = "2000",
language = "English",
volume = "9",
pages = "705--709",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "5",

}

TY - JOUR

T1 - Grafting of encapsulated dopamine-secreting cells in Parkinson's disease

T2 - Long-term primate study

AU - Date, Isao

AU - Shingo, Tetsuro

AU - Yoshida, Hideyuki

AU - Fujiwara, Kenjiro

AU - Kobayashi, Kazuki

AU - Ohmoto, Takashi

PY - 2000

Y1 - 2000

N2 - The transplantation of encapsulated dopamine-secreting cells into the striatum represents one potential means of treating Parkinson's disease. The present study investigated the ability of encapsulated PC12 cells, which are derived from rat pheochromocytoma, to supply L-dopa and dopamine into the primate brain in the long term and to effect functional improvement in the animals. Following polymer encapsulation, PC12 cells were transplanted into the striatum of hemiparkinsonian monkeys. The secretion of L-dopa and dopamine from the encapsulated cells, the morphology of these cells, the histology of the host striatum surrounding the capsule, and functional changes in the host animals were examined 1, 6, and 12 months after transplantation. Analysis of retrieved capsules revealed that the PC12 cells survived and continued to release L-dopa and dopamine even 12 months after transplantation. The histological response of the host brain surrounding the capsules was minimal and there were no signs of immunological rejection or tumor formation. The physical condition of the host animals was good for 12 months, and hematologic and cerebrospinal fluid analysis revealed that no animals suffered from infection or immunological reaction. These PC12 cell-grafted monkeys showed improvements in hand movements after transplantation, effects that lasted for at least 12 months. These results further support the potential use of this approach for the treatment of Parkinson's disease.

AB - The transplantation of encapsulated dopamine-secreting cells into the striatum represents one potential means of treating Parkinson's disease. The present study investigated the ability of encapsulated PC12 cells, which are derived from rat pheochromocytoma, to supply L-dopa and dopamine into the primate brain in the long term and to effect functional improvement in the animals. Following polymer encapsulation, PC12 cells were transplanted into the striatum of hemiparkinsonian monkeys. The secretion of L-dopa and dopamine from the encapsulated cells, the morphology of these cells, the histology of the host striatum surrounding the capsule, and functional changes in the host animals were examined 1, 6, and 12 months after transplantation. Analysis of retrieved capsules revealed that the PC12 cells survived and continued to release L-dopa and dopamine even 12 months after transplantation. The histological response of the host brain surrounding the capsules was minimal and there were no signs of immunological rejection or tumor formation. The physical condition of the host animals was good for 12 months, and hematologic and cerebrospinal fluid analysis revealed that no animals suffered from infection or immunological reaction. These PC12 cell-grafted monkeys showed improvements in hand movements after transplantation, effects that lasted for at least 12 months. These results further support the potential use of this approach for the treatment of Parkinson's disease.

KW - Encapsulation

KW - Neural transplantation

KW - Parkinson's disease

KW - PC12 cells

UR - http://www.scopus.com/inward/record.url?scp=0034533051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034533051&partnerID=8YFLogxK

M3 - Article

C2 - 11144970

AN - SCOPUS:0034533051

VL - 9

SP - 705

EP - 709

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 5

ER -